中文摘要：

本研究旨在探讨细胞外信号调节激酶1/2（extracellular signal-regulated kinase，ERK1/2）信号通路在慢性哮喘模型大鼠支气管平滑肌细胞（bronchialsmooth muscle cells，BSMCs）迁移能力改变中的调控作用。应用卵清蛋白致敏和雾化方法制备大鼠慢性哮喘模型，体外培养大鼠BSMCs，采用免疫荧光细胞化学、Western blot和RT-PCR方法检测ERK1／2信号通路的表达，分别用平面迁移实验和跨膜迁移实验来评价BSMCs的活动和趋向迁移能力，并比较用和不用ERK1／2信号通路干预剂的差异。Western blot结果显示慢性哮喘模型大鼠BSMCs中总ERK1／2（9．13±0．87）较对照组（4．68±0．59）明显增加，磷酸化ERK1／2（P．ERK1／2）占总ERK1／2的比值（0．55±0．05）较对照组（0．48±0．04）显著提高（n=10，P〈O．01）。慢性哮喘组ERKI和ERK2mRNA的表达（1．83±0．24和1．07±0．11）较对照组（0．58±0．14和0．51±0．12）明显增高（n=10，P〈O．01）。在平面迁移实验中，慢性哮喘大鼠BSMCs的迁移最远距离是对照组的（2．9±0．1）倍，在ERK1／2激动剂表皮生长因子（epidermal growth factor，EGF）刺激下增加到（5．0±0．2）倍，而在30μmol／LPD98059的作用后下降到（1．7±0．2）倍。正常对照大鼠BSMCs平面迁移能力对PD98059的反应较慢性哮喘组弱，仅在100μmol／L PD98059的作用下下降到（0．8±0．1）倍。跨膜迁移实验中，慢性哮喘大鼠BSMCs的跨膜迁移细胞是对照组的（1．9±0．1）倍，在EGF刺激下增加到（3．1±0．2）倍，而在30μmol／LPD98059作用后下降到（1．45±0．2）倍。这些结果表明慢性哮喘模型大鼠BSMCs的迁移能力明显增强，ERK1/2信号通路在该功能变化的调控中可能发挥了重要作用。

英文摘要：

This work was designed to explore the role of extracellular signal-regulated kinase 1/2 （ERK1/2） signaling pathway in migration of bronchial smooth muscle cells （BSMCs） of chronic asthmatic rats. To make chronic asthma model, Wistar rats underwent ovabumin （OVA） injection and eight-week inhalation. BSMCs were cultured in vitro. The expression of ERKI/2 in BSMCs was analyzed by immunocytochemistry, Western blot and RT-PCR. Migration of BSMCs was detected by both plate test and Boyden cell test. Results showed： （1） With Western blot technique, the ratio of p-ERKI/2 to total ERKI/2 in chronic asthmatic group was obviously higher than that in the control group （0.55±0.05 vs 0.48±0.04, n=10, P〈0.01）. （2） With RT-PCR, the relative A values of ERK1 and ERK2 mRNA in airways of chronic asthmatic rats were 1.83±0.24 and 1.07±0.11, respectively, which were significantly increased compared with that in the control group （0.58±0.14 and 0.51±0.12, n=10, P〈O.01）. （3） In plate test, the migration of BSMCs of chronic asthmatic rats was 2.9 times of that in the control group and reached 5.0 times by epidermal growth factor （EGF） stimulation, but decreased to 1.7 times by 30 μmnol/L PD98059. （4） In Boyden cell test, the migration of BSMCs of chronic asthmatic rats was 1.9 times of that in the control group, and reached 3.1 times by EGF stimulation, but decreased to 1.45 times by 30 μmol/L PD98059. Our results indicate that the migration ability of BSMCs of chronic asthmatic rats increases, and ERK1/2 signaling pathway may play an important role in this process.